Skip to content
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT

Patient access today

Rethinking the clinical paradigm through Real-World Evidence. Accelerating access for those suffering most in society.

About us

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines

RWE studies are increasingly recognized as a regulatory pathway which accelerates the time taken to treat patients with urgent and unmet needs. It has been successfully used throughout history for the licensing of medicines, notably the development of Covid-19 vaccines and a number of cancer treatments.

RWE is at the forefront of our regulatory strategy as we seek to deliver on our goal of receiving marketing authorisations for our medicines.

We utilise existing clinical infrastructure, through collaborations with research institutions, hospital centres and government agencies, to deliver and improve patient access to our treatments.

KRN-101, is a potential solution for cancer-related anxiety, a market of over 15 million people with roughly 1 million new sufferers each year. From this initial focus, we will address broader mental health concerns reported to affect over a billion people worldwide.

We are a publicly-traded company listed on the Canadian Securities Exchange (CSE:ABRT) and Frankfurt Stock Exchange (FSE:VB50).

Supporting mental health and more

Tens of millions of people are diagnosed with cancer each year, and millions more are living with it. The depression and anxiety that might accompany cancer is self-evident, more commonly known as cancer distress.

Fatigue, worry, insomnia, sadness, fear, and doubts regarding the meaning of one’s life are commonplace with a cancer diagnosis.

Due to the complexities surrounding cancer therapy, too often, patient’s psychological needs are left untreated. 

Our Clinical Trials

+500 Million People

Suffer from anxiety and depression disorders worldwide. [1] 

Unmet Medical Need

With only 1 in 3 patients responding to treatment within 12 weeks. [2] 

A Real Global Crisis

In 2022 it was reported that 1 in 8 adults worldwide live with a mental health disorder. [3] 

The Emerging Pandemic

A recent study showed that 30% of people consider their mental health to be their biggest concern since the Covid-19 outbreak.[4] 

Our Values

Treating mental health is about helping those who feel helpless. To solve the mental health crisis, suffering must be alleviated on an individual level and at scale.

At Albert Labs, we are held accountable to our promise of treating patients with urgent and unmet mental health needs. The driving force behind our decisions is the wellbeing of the people we serve.

We do so with compassion, collaboration, innovation and responsibility.

Compassion

Everyone has been impacted by the mental health crisis in someway. We have all seen or experienced the debilitating pressure of mental illness. Our team are no exception and our work is grounded in personal experiences.

We take a patient-first approach and always will. Through our Real-World Evidence studies, access to our therapy for those currently suffering is possible. It is our priority to meet and treat the needs of those we serve.

The Unmet Need

Collaboration

To meet the global needs of the mental health crisis collaboration is essential. We work with established and leading institutions to deliver our medicine and therapy.

Through Real-World Evidence we work with real people in their home environment and listen to & learn about their needs.

Our Partners

Innovation

Natural medicines like ours require innovation to ensure consistent, scalable and cost effective production. The large and growing unmet need for mental health treatments require constant and continuous development to adapt. It is through innovation that we can change lives and solve the mental health crisis.
Our Asset

Responsibility

Albert Labs team has a diverse range of skills and expertise including world-renowned researchers, university professors, ex-regulators, ex-big pharma senior management and more. It is our responsibility to ensure our novel therapy is delivered with safety and care. We believe our team is one of the best equipped in the world to do this.

Our team

Innovative mental health medicines for patients with unmet needs

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy

© 2024 Albert Labs. All Rights Reserved

  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Twitter Linkedin Youtube Envelope
CSE:ABRT
FSE: VB50
CSE:ABRT
FSE: VB50

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact [email protected]

Twitter Linkedin Youtube Envelope

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

  • This field is for validation purposes and should be left unchanged.
Twitter
Youtube
Linkedin
Instagram
Envelope
Twitter
Youtube
Linkedin
Instagram
Envelope

Latest Press Release

Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors

Read more

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok